参考文献/References:
[1]Ulrike S,Wolfgang W,Franziska A,et al.MACC1, a newly identified key regulator of HGF-MET signaling,predicts colon cancer metastasis[J].Nat Med,2009,15(1):59-67.[2]Tong GL,Cheng B,Li JZ,et al.MACC1 regulates PDL1 expression and tumor immunity through the c-Met/AKT/Mtor pathway in gastric cancer cells[J].Cancer Med,2019,8(16):7044-7054.[3]Shi W,Song J,Wang W,et al.MACC 1 antibody target therapy suppresses growth and migration of non small cell lung cancer[J].Mol Med Rep,2017,16(5):7329-7336.[4]Dahlmann M,Werner R,Kortüm B,et al.Restoring Treatment Response in Colorectal Cancer Cells by Targeting MACC1-Dependent ABCB1 Expression in Combination Therapy[J].Front Oncol,2020,10:599.[5]Makino T,Orita Y,Gion Y,et al.MACC1 expression is an indicator of recurrence in early-stage glottis cancer[J].Jpn J Clin Oncol,2020,50(4):392-398.[6]Wen J,Xie Y,Zhang Y,et al.MACC1 contributes to the development of Osteosarcoma through regulation of the HGF/c-Met pathway and microtubule stability[J].Front Cell Dev Biol,2020,8:825.[7]Trovato M,Campennì A,Giovinazzo S,et al.Hepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic Target[J].Biomarker Insights,2017,12:1-8.[8]Tong H,Liu X,Li T,et al.MACC1-AS1 promotes hepatocellular carcinoma cell invasion and proliferation by regulating PAX8[J].Aging (Albany NY),2020,12(1):70-79.[9]Czerniak B,Olszewska-SloninaD,Cwynar A.S100A4, MACC-1, REG-4-promising biomarkers of metastasis in cancers[J].Wiad Lek,2017,70(3):604-607.[10]Li Z,Yanfang W,Li J,et al.Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer[J].Cancer Lett,2018,432:237-250.[11]Wang L,Zhou R,Zhao Y.MACC-1 Promotes Endothelium-Dependent Angiogenesis in Gastric Cancer by Activating TWIST1/VEGF-A Signal Pathway[J].PLoS One,2016,9:11.[12]Peng T,Li Z,Li D,et al.MACC1 promotes angiogenesis in cholangiocarcinoma by upregulating VEGFA[J].Onco Targets Ther,2019,12:1893-1903.[13]Zheng D,Che D,Lin F,et al.LncRNA MACC1-AS1/MACC1 enhances the progression of glioma via regulating metabolic plasticity[J].Cell Cycle,2020,19(18):2286-2297.[14]Budczies J,Kluck K,Walther W,et al.Decoding and targeting the molecular basis of MACC1-driven metastatic spread: Lessons from big data mining and clinical-experimental approaches[J].Semin Cancer Biol,2020,60:365-379.[15]Hohmann T,Hohmann U,Kolbe MR,et al.MACC1 driven alterations in cellular biomechanics facilitate cell motility in glioblastoma[J].Cell Commun Signal,2020,18(1):85.[16]Lin CH,Hsieh MJ,Lee HL.Effects of MACC1 polymorphisms on hepatocellular carcinoma development and clinical characteristics[J].J Cancer,2020,11(6):1641-1647.[17]王瑾,韩若凌,张凤娟.Gelectin-3、c-met、HBME-1及CK19表达结合超声对于甲状腺癌淋巴结转移及预后的评估价值[J].中华超声影像学杂志,2018,27(11):963-967.[18]王艳,王倩,赵永明,等.c-Met在甲状腺癌中的表达及其临床病理意义[J].浙江医学,2015,37(3):208-210.[19]马泽忠,刘建,李自力.甲状腺乳头状癌患者血清MACC1及糖类抗原的表达及预后[J].热带医学杂志,2019,5(8):987-990.[20]Ahmed M,Aslam M.Serum MACC-1:a new biomarker for breast cancer[J].Oncotarget,2020,11(48):4521-4526.
相似文献/References:
[1]李 想,孙春雷,张 懿,等.无充气腋窝入路腔镜手术治疗甲状腺乳头状癌的疗效研究[J].医学信息官方网站,2021,34(04):115.[doi:10.3969/j.issn.1006-1959.2021.04.030]
LI Xiang,SUN Chun-lei,ZHANG Yi,et al.Study on the Curative Effect of Laparoscopic Surgery Non-inflated Axillary Approach in the Treatment of Papillary Thyroid Carcinoma[J].Medical Information,2021,34(15):115.[doi:10.3969/j.issn.1006-1959.2021.04.030]
[2]刘 彻,艾力·赛丁,苏鹏程.甲状腺乳头状癌颈部淋巴结转移特点及相关危险因素分析[J].医学信息官方网站,2019,32(23):70.[doi:10.3969/j.issn.1006-1959.2019.23.019]
LIU Che,Aili·SaiDing,SU Peng-cheng.Analysis of Cervical Lymph Node Metastasis and Related Risk Factors in Papillary Thyroid Carcinoma[J].Medical Information,2019,32(15):70.[doi:10.3969/j.issn.1006-1959.2019.23.019]
[3]唐嘉晨,郝玲玲,秦晓茹,等.全腔镜下甲状腺乳头状癌并发症Meta分析[J].医学信息官方网站,2021,34(04):78.[doi:10.3969/j.issn.1006-1959.2021.04.021]
TANG Jia-chen,HAO Ling-ling,QIN Xiao-ru,et al.Meta-analysis of Complications of Papillary Thyroid Carcinoma Under Full Laparoscopic Surgery[J].Medical Information,2021,34(15):78.[doi:10.3969/j.issn.1006-1959.2021.04.021]
[4]范雪峰,王伦锋,余招焱,等.左侧及右侧中央区淋巴结清扫在甲状腺乳头状癌术中的应用[J].医学信息官方网站,2021,34(09):5.[doi:10.3969/j.issn.1006-1959.2021.09.002]
FAN Xue-feng,WANG Lun-feng,YU Zhao-yan,et al.Left and Right Central Lymph Node Dissection in the Operation of Papillary Thyroid Carcinoma[J].Medical Information,2021,34(15):5.[doi:10.3969/j.issn.1006-1959.2021.09.002]
[5]徐海燕,潘景润,宫希军,等.CT增强联合甲状腺球蛋白及抗体在甲状腺乳头状癌颈部淋巴结转移中的预测价值[J].医学信息官方网站,2021,34(20):119.[doi:10.3969/j.issn.1006-1959.2021.20.030]
XU Hai-yan,PAN Jing-run,GONG Xi-jun,et al.The Value of CT Enhancement Combined with Thyroglobulin and Antibody in PredictingCervical Lymph Node Metastasis of Papillary Thyroid Carcinoma[J].Medical Information,2021,34(15):119.[doi:10.3969/j.issn.1006-1959.2021.20.030]
[6]李佳楠,陈春悠.STAT3、NCK1和VEGF在甲状腺乳头状癌中的表达及临床意义[J].医学信息官方网站,2022,35(05):94.[doi:10.3969/j.issn.1006-1959.2022.05.023]
LI Jia-nan,CHEN Chun-you.Expression of STAT3, NCK1 and VEGF in Papillary Thyroid Carcinoma and its Clinical Significance[J].Medical Information,2022,35(15):94.[doi:10.3969/j.issn.1006-1959.2022.05.023]
[7]李雪松,苏新良,陶冬梅.术前诊断不明确的甲状腺乳头状癌的风险分析[J].医学信息官方网站,2024,37(04):119.[doi:10.3969/j.issn.1006-1959.2024.04.021]
LI Xue-song,SU Xin-liang,TAO Dong-mei.Risk Analysis of Papillary Thyroid Carcinoma with Undefinable Preoperative Diagnosis[J].Medical Information,2024,37(15):119.[doi:10.3969/j.issn.1006-1959.2024.04.021]